Physician profile
Ryan Eric Allen
NPI 1376172650
$1,215.80
in general payments reported to CMS, 2019-2025
16 companies · $787 in 2025
The $787 reported for 2025 was more than what 87% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $429 · 2025: $787.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,215.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $235.14 | 2024-2025 | Airsupra |
| Abbott Laboratories | $169.25 | 2024 | Freestyle Libre 3 |
| Phathom Pharmaceuticals, INC. | $167.50 | 2024 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2025 | |
| Sanofi-Aventis U.S. LLC | $121.81 | 2025 | |
| Novo Nordisk INC | $118.11 | 2025 | Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $93.28 | 2024-2025 | Jardiance |
| Amgen INC. | $27.67 | 2025 | Krystexxa |
| Sanofi Pasteur INC. | $26.87 | 2025 | |
| Boston Scientific Corporation | $26.17 | 2025 | General - Pain Management |
| Lucid Diagnostics INC. | $21.72 | 2025 | |
| Lundbeck LLC | $19.24 | 2025 | Rexulti |
| Merck Sharp & Dohme LLC | $17.70 | 2024 | Capvaxive, Gardasil 9, Gardasil |
| E.R. Squibb & Sons, L.L.C. | $16.39 | 2024 | Camzyos |
| Lilly USA, LLC | $15.80 | 2025 | Zepbound, Mounjaro |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $14.15 | 2025 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.